DynaMed Plus (EBSCO) – point-of-care clinical guidelines

• COVID-19

COVID-19 Resilience Hub (NHS) – advice and tips

NHS has drawn together the best advice and tips from their large panel of international experts to guide you and your team. This hub is for everyone on the front line health and care services.

Trends in epidemiology

GIDEON*, Global Infectious Diseases and Epidemiology Online Network, a unique resource dedicated to the detection, prevention, and education of infectious diseases, is ideal for anyone working in this critical, fast-paced field, including: clinicians, educators, policymakers, drug makers, and researchers. This multimedia resource features up-to-date information and visual tools for diagnosing diseases and following the latest trends in epidemiology and treatment.

View the tutorial here to learn how to find COVID-19 information in Gideon

* Access from UGent / UZ Gent network is required

Evidence summaries:

EvidenceAid is drawing on the Cochrane Special Collections and other systematic reviews.

Do you have another PICO question and need an evidence summary? The KCGG can advise you on this.

Literature hub for scientific information about COVID-19:

LitCovid is a literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is a central access point to relevant articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access.

WHO COVID-19 Database collects the latest international multilingual scientific findings and knowledge on COVID-19. The majority of citations referenced are published journal articles. The global literature cited in the WHO COVID-19 database is updated daily from searches of bibliographic databases, hand searching, and the addition of other expert-referred scientific articles. Particular emphasis is placed on identifying literature from around the world.

The Coronavirus Research Database of PROQUEST curates openly available content related to coronaviruses. This database brings together trusted content from journals, preprints, conference proceedings, dissertations and more related to COVID-19 and other coronaviruses. This database brings together, next to the content from open-access journals, also pre-prints and additional content being made freely available by major publishers from around the world.

Selected journal articles

Some Publishers make coronavirus (COVID-19) content freely available and reusable. An overview can be found in this research tip.

The following articles have a high Altmetric score and/or have many citations:

• “The proximal origin of SARS-CoV-2” (Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature medicine, 26(4), 450-452.)

• “Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” (Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet.)

• “Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1” (Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., … & Lloyd-Smith, J. O. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564-1567.)

• “COVID-19 Antibody Seroprevalence in Santa Clara County, California” (Bendavid, E., Mulaney, B., Sood, N., Shah, S., Ling, E., Bromley-Dulfano, R., … & Tversky, D. (2020). COVID-19 Antibody Seroprevalence in Santa Clara County, California. MedRxiv.)

• “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China” (Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.)

• “A Novel Coronavirus from Patients with Pneumonia in China, 2019” (Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., … & Niu, P. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine.)

• “Clinical Characteristics of Coronavirus Disease 2019 in China” (Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., … & Du, B. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.)

• “Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China” (Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., … & Zhao, Y. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 323(11), 1061-1069.)

• “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study” (Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … & Yu, T. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507-513.)

Tip: Follow the latest COVID-19 literature via Read by QxMD. (Read by QxMD is a personalized medical & scientific platform that allows clinicians to keep up with the latest new research that impacts their practice. Read is integrated with full text holdings at Ghent University. Read is available for iPhone, iPad, Android tablets & smartphone, and the web. Click here to get Read now.)

Selected e-book

Zhang, W. (2020). Prevention and Control of COVID-19. World Scientific Publishing.

Coronavirus e-learning programme (free of charge)

This programme brings together quality-assured content from Health Education England e-Learning for Healthcare, NHS England and NHS Improvement, and the World Health Organization (WHO). The programme is suitable for doctors, nurses, consultants, healthcare assistants, midwives and other allied healthcare professionals, including those who are returning to the workforce to help during the current crisis.

latest update: 4/02/2021